Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose FP vs SFC in Allergic Asthma
NCT00456313Phase 4Withdrawn
- Sponsor
- GSK
- Start
- Dec 2007
- Primary completion
- Dec 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone propionate, salmeterol in allergic asthma, sponsored by GSK. Planned start Dec 2007; status: withdrawn.
02
Drugs
fluticasone propionatesalmeterol
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT00456313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00456313.